Company intelligence / Profile preview
Vedanta Biosciences
Cambridge, Massachusetts, United Statesvedantabio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Vedanta’s lead candidate VE303 demonstrated a >80% reduction in the odds of rCDI recurrence compared to placebo in a Phase 2 trial. VE303 was well tolerated with no serious drug-related adverse events. A pivotal global Phase 3 study (RESTORATiVE303) for rCDI prevention is ongoing with topline data expected in 2026. Additional candidates are advancing through mid-stage trials for ulcerative colitis and food allergy indications
- Therapeutic areas
- GastroenterologyOncologyImmunologyInfectious Diseases
- Modalities
- Live biotherapeutic products (LBPs)defined bacterial consortia
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
03
Partnerships
BARDA (Biomedical Advanced Research and Development Authority) supports development of VE303collaborations with academic institutions not specified by name but implied by scientific network and publications
Beyond the preview
Go deeper on Vedanta Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vedanta Biosciences.